Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Equity Average (2020 - 2025)

Journey Medical (DERM) has disclosed Equity Average for 6 consecutive years, with $22.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Average rose 103.16% year-over-year to $22.6 million, compared with a TTM value of $22.6 million through Sep 2025, up 103.16%, and an annual FY2024 reading of $20.2 million, up 8.27% over the prior year.
  • Equity Average was $22.6 million for Q3 2025 at Journey Medical, up from $20.4 million in the prior quarter.
  • Across five years, Equity Average topped out at $41.7 million in Q1 2022 and bottomed at -$6.3 million in Q3 2021.
  • Average Equity Average over 5 years is $16.8 million, with a median of $15.5 million recorded in 2024.
  • The sharpest move saw Equity Average skyrocketed 664.24% in 2022, then tumbled 90.17% in 2023.
  • Year by year, Equity Average stood at $15.2 million in 2021, then surged by 42.3% to $21.6 million in 2022, then dropped by 12.61% to $18.9 million in 2023, then dropped by 17.84% to $15.5 million in 2024, then soared by 45.65% to $22.6 million in 2025.
  • Business Quant data shows Equity Average for DERM at $22.6 million in Q3 2025, $20.4 million in Q2 2025, and $20.8 million in Q1 2025.